Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.

@article{Efstathiou2012LongtermOO,
  title={Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.},
  author={Jason Alexander Efstathiou and Daphna Y Spiegel and William U. Shipley and Niall M. Heney and Donald S. Kaufman and Andrzej Niemierko and John J. Coen and Rafi Y Skowronski and Jonathan J. Paly and Francis J McGovern and Anthony Laurence Zietman},
  journal={European urology},
  year={2012},
  volume={61 4},
  pages={705-11}
}
BACKGROUND Whether organ-conserving treatment by combined-modality therapy (CMT) achieves comparable long-term survival to radical cystectomy (RC) for muscle-invasive bladder cancer (BCa) is largely unknown. OBJECTIVE Report long-term outcomes of patients with muscle-invasive BCa treated by CMT. DESIGN, SETTING, AND PARTICIPANTS We conducted an analysis of successive prospective protocols at the Massachusetts General Hospital (MGH) treating 348 patients with cT2-4a disease between 1986 and… CONTINUE READING
Highly Influential
This paper has highly influenced 10 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS